Hematology Update 2020

Hematology Update 2020 is organized by George Washington University School of Medicine & Health Sciences (GWSMHS) and will be held on Feb 22, 2020 at Falls Church Marriott Fairview Park, Falls Church, Virgina, United States of America.

Target Audience:
This symposium is designed for hematology and oncology clinicians; internal medicine physicians; oncology nurses; physician assistants; and other health care professionals.

Accreditation:
Physicians:
The George Washington University School of Medicine and Health Sciences designates this live activity for a maximum of 5.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Description:
Presented on behalf of the GW Cancer Center, this one-day program provides an extensive update of the latest diagnostic and therapeutic advances in the field of hematology. A panel of leading experts will present cutting-edge research, new guidelines, and recent abstracts from major hematology meetings. Hematology Update also offers practical strategies to help incorporate these advances into daily clinical practice.

Learning Objectives:
At the conclusion of this activity, participants should be able to:
• State advances in the scientific understanding of acute myeloid leukemia
• Discuss current and evolving AML therapeutic strategies
• Summarize current applications of bone marrow transplantation and hematopoietic stem cell transplantation in the management of malignant diseases
• Describe the role of CAR T-cell therapy in the treatment of including acute myeloid leukemia, chronic lymphocytic leukemia and other hematologic malignancies
• Outline current advances in treatment for chronic lymphocytic leukemia
• Review current guidelines for the management of coagulation disorders
• Outline therapies of choice for venous thromboembolism and thrombotic thrombocytopenic purpura
• Define the factors that influence treatment decisions for patients with non-Hodgkin and Hodgkin lymphoma
• Summarize diagnostic and therapeutic criteria for myeloproliferative neoplasms
• Apply insights from current understanding and emerging data on multiple myeloma when formulating individualized treatment plans.